November '18 ... RAC traded 42 million in one day (when there...

November '18 ... RAC traded 42 million in one day (when there were far less shares than currently). Before M.
and this was the news that set it all off on Nov 1

Race appoints Biosynergy to pursue Bisantrene licensing
1 November 2018: Race Oncology Limited (‘RAC’) announced that it has executed a services
agreement with Biosynergy Partners LLC (‘Biosynergy’) to pursue licensing and other dealsfor
Bisantrene (the ‘Agreement’). Biosynergy is a transaction consulting business owned by Dr
John Cullity, a non-executive director of RAC.
Under the Agreement, potential transactions include any sale, license, partnership,
collaborative venture or other arrangement, whereby an interest in Bisantrene is transferred
to a third party (‘Transaction’).
Dr Cullity will work with RAC management to prepare licensing presentations and due
diligence materials for prospective partners, identify and engage with potential partners, and
seek to structure, negotiate and close a Transaction.

Ask yourself ... who's playing the fiddle - really?